Biotech 2050 Podcast
Advancing RNA medicines in genetic diseases, Paul Bolno, President & CEO, Wave Life Sciences
about a year ago
Leadership in revolutionizing cancer immunotherapy, Garo Armen, Ph.D., Chairman & CEO, Agenus
about a year ago
Revolutionizing brain health: CNS innovations, AI & more, Craig Thompson, CEO, Cerevance
about a year ago
Mental health: psychedelics & beyond, Florian Brand, CEO, & Srinivas Rao, CSO, atai Life Sciences
about a year ago
High-impact oral small molecule therapy in autoimmune disease, Kevin Judice,Co-Founder & CEO,DICE Tx
about a year ago
A new vision in inflammatory disease: RNAseq led precision medicine, Tariq Kassum, CEO, Celsius Tx
about a year ago
Pioneering therapeutics targeting cellular stress pathways, Prakash Raman, President & CEO, Ribon Tx
about a year ago
Novel viral vectors in gene therapy, Joel Schneider, CEO & Robert Kotin, Founder, Carbon Biosciences
about a year ago
Advancing medicines that matter, Matt Gline, CEO, Roivant Sciences
about a year ago